In line with our results, a recent study on cervical cancer and recurrence elucidated the context between high expression of HLA-DQB1 and high survival rate, as compared to patients with low expression of HLA-DQB1 (40). This evidence concerns the gene HLA-DQB1 and cervical carcinoma.